Despite the reduced activity of the DNA-PK complex, CML patients accumulate chromosome aberrations as seen in B-CLL patients and the deficiency in DNA repair is counterbalanced by resistance to apoptosis [77]. This evidence concerns the gene PRKDC and chronic myelogenous leukemia, BCR-ABL1 positive.